ArticleActa oncologica (Stockholm, Sweden)2026
Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.
Meeri Maunu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it